Video summary
The 90-Day Protocol That Reverses Insulin Resistance | Labs & Supplements - Dr Trevor Bachmeyer
Main summary
Key takeaways
Key wellness / metabolic reset strategies from the subtitles
Understand insulin resistance as a cellular problem
- Cells “close the door” to glucose because they’re full, not because they’re “lazy.”
- The root cause is framed as mitochondrial overload + low mitochondrial capacity, leading to:
- Fat accumulation inside muscle cells (IMCL: intramyocellular lipid)
- IMCL is described as strongly predictive of insulin resistance and said to sabotage insulin signaling (via ceramides interfering with IRS1).
Stop treating symptoms; target systemic inflammation
- Insulin resistance is argued to be downstream of systemic inflammation.
- Examples mentioned: TNF-α, IL-1β, IL-6, and JNK activity impair IRS1 signaling (as claimed).
- Gut barrier leakage / endotoxemia (LPS) is described as one inflammation driver that worsens insulin resistance.
90-day “protocol” (timing, diet, training, inflammation control)
Intermittent fasting schedule (strict)
- Eating window: 12:00 p.m. – 6:00 p.m.
- Fasting: 6:00 p.m. – 12:00 p.m. the next day
- During fasting: water, black coffee, plain green tea
- Avoid anything with calories/amino acids, because it “breaks the fast” and is said to trigger insulin.
Diet pattern: “strategic carnivore (with post-workout carbs)”
- Prioritize:
- Meat (including organ meats)
- Eggs
- Butter
- Sea salt
- Wild-caught fish (optional)
- Avoid:
- Processed foods, seed oils, refined carbs
- These are framed as inflammatory triggers.
Training + “strategic post-workout carbohydrates”
- Pre-workout options: meat/fat/salt (e.g., grass-fed beef, wild fatty fish, organ meat, eggs, butter)
- Post-workout within ~30 minutes:
- 50–75 g white rice (speaker emphasizes white rice)
- 30–40 g beef protein (or fish)
- Reasoning given:
- Post-workout carbs support glycogen repletion
- They’re also claimed to support T4 → T3 conversion.
Electrolytes during the transition (to prevent “keto flu”)
Suggested daily electrolyte targets (as stated):
- Sodium: ~5–7 g/day
- Potassium: ~3–4 g/day
- Magnesium: ~500 mg/day (e.g., magnesium glycinate mentioned)
Rationale:
- When insulin drops (especially when starting carnivore), the kidneys dump sodium/water; electrolytes help prevent feeling severely unwell.
Use monitoring tools to avoid overcorrection
- Get labs
- Use CGM (continuous glucose monitor) to guide adjustments (especially with peptides/drugs).
Peptide add-ons for “metabolic reset” (with medication titration)
Note: The subtitles include strong medical claims, aggressive language, and dosing instructions for prescription/peptide-like interventions. Treat the following as extracted discussion points, not medical advice.
- The speaker emphasizes these are not a “magic bullet” and should be paired with the diet/timing approach.
“Retatrutide” (referred to as “retatrutide/Red truth”-type peptide)
- Claimed purpose: force cells toward fat-burning; affects AMPK/mTOR balance (speaker’s framing).
- Suggested titration structure (as stated):
- Start 0.5 mg once weekly
- Increase gradually every 1–2+ weeks (step-up example to several mg weekly mentioned)
- Adjust based on response; use CGM
- If fasting glucose drops too low: reduce diabetes meds
“MHC/mosC”-type peptide (subtitles reference “MOC/Met…”, dosing mentioned)
- Claimed to shift metabolism toward fat oxidation; described as “exercise in a bottle.”
- Example stated:
- Start ~5 mg once weekly
- Can split (e.g., Mon/Thu)
- May go higher depending on protocol
BPC-157
- Claimed benefits:
- Endothelial repair
- Increased nitric oxide
- Less endothelin-1
- Gut barrier support
- Collagen/connective tissue repair
- Example stated: 500 micrograms twice daily
- Duration mentioned: 90 days minimum (timing emphasized)
Thymosin alpha-1
- Framed as immune-related support (macrophage polarization shift mentioned).
- Example dosing stated:
- 1 mg three times per week
- “Start low” approach for early weeks
Epitoolon (subtitles: “Epitooline” / “epitoolon”)
- Framed as circadian/endocrine axis support (melatonin + HPA/pineal/hypothalamus alignment mentioned).
- Example:
- 10 mg for 10 days
- Repeated about every 6 months (spring/fall timing mentioned)
Medication caution
- If using peptides that lower glucose:
- The speaker warns to titrate down diabetes medications to avoid hypoglycemia
- Uses CGM/fasting glucose to guide adjustments.
Productivity / self-care elements mentioned (lighter than metabolic content)
Don’t rely on “cheap” or low-trust advice
- Criticism of relying on:
- One lab marker (especially A1C)
- “Insta bros” or generic protocols
Take “due diligence” with health
- Emphasis on getting the right labs and using data to adjust the protocol.
Discipline over convenience
- Results are framed as requiring strict adherence for ~90 days (not “easy mode”).
Key labs / metrics the speaker says to track
Insulin resistance
- Fasting insulin
- Fasting glucose
- HOMA-IR (described as fasting glucose × fasting insulin / 22.5 or / 405 depending on units)
- Targets mentioned:
- Optimal HOMA-IR: < 0.8
- Solid insulin resistance: > ~1.5
- “Metabolic crisis”: > 3
A1C (HbA1c)
- Criticized as missing insulin resistance.
- Described as reflecting ~120-day RBC lifespan and being “behind the curve.”
Inflammation
- CRP target: < 0.5
Cardiometabolic risk
- ApoB emphasized over LDL alone.
Thyroid / liver conversion
- TSH
- Free T3
- Free T4
- Reverse T3
- CMP, including ALT and GGT
- GGT flagged as possibly indicating liver congestion/oxidative stress (as stated)
Nutrients / cofactors
- Ferritin
- RBC magnesium (not serum)
- Vitamin D
- Vitamin B12 and folate
Other
- Uric acid target: < 5.5
Presenters / sources named in the subtitles
- Dr. Trevor Bachmeyer (presenter; name appears as “Dr. Trevor Bachmire/Bachmeyer”)
- Gerald Schulman (Yale University; Journal of Clinical Investigation, 2004 referenced)
- Barbara Khan (Harvard Medical School)
- Dr. Vassera (2007 referenced; glycation context mentioned)
- Michael Pollock McIll (2008 referenced; insulin binding/growth receptor discussion)
- Dr. Eugeneia Gi(o) venzucci (Harvard; 2012 Journal of Clinical Oncology referenced)
- Stern (Matthews?) (2004 referenced; HOMA-IR validation in Diabetes Care)
- 2017 Gustell Delhi (metabolic syndrome / HOMA-IR cardiovascular mortality referenced)
- Osborne (2010 referenced; JNK activation → IRS1 phosphorylation)
- Kaniai/Canai (Nature study, 2007 referenced: high-fat diet → gut permeability → endotoxemia → insulin resistance)
- Lee (2018 referenced; AMPK / metabolic effects in Cell Metabolism)
- Lou (2019 referenced; time-restricted eating reduces HOMA-IR in New England Journal of Medicine)
- Yale / Harvard / Duke / University of Washington (institutions cited generally)
- Weightin Diabetes (cited for T4 → T3 conversion requires glucose; author not clearly identified)
- Shannabi (2022 referenced; carnivore + strategic post-workout carbs reduces HOMA-IR in Nutrients)
- Sea(wo)rth / Seaworth (BPC-157 vascular benefits referenced; journal not specified)
- Goldstein (2015 referenced; Annals of the New York Academy of Sciences for thymosin alpha-1/immune balance)
- Cavinson (2013 referenced; epitoolone/epitoolon circadian/glucose homeostasis; journal not specified)
Some names/titles appear garbled due to auto-generation; only identifiable entries from the subtitles were included.